Skip to main content
F
Formulate
Jobs
Companies
Drugs
Advisor
NEW
Insider Intel
Salary
Pricing
Toggle theme
Toggle theme
Menu
argenx Jobs | Formulate
Jobs
argenx
argenx Jobs
Belgium - Zwijnaarde
Biotechnology
argenx is a life sciences company focused on Antibody therapies.
46
open positions at argenx
View Full Profile
Project Manager, Governance Forums
argenx
Posted 2d ago
Remote
$212K - $292K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Immunology
H-1B · 1 FY23
Associate Director, US Patient Advocacy
argenx
Posted 3d ago
Remote
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Immunology
Executive
H-1B · 1 FY23
Associate Director Medical Information – Customer Management
argenx
Posted 3d ago
Remote
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Medical Affairs
Immunology
Executive
H-1B · 1 FY23
Director, Market Access Lead
argenx
Posted 3d ago
Remote
$175K - $337K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Commercial
Immunology
Executive
H-1B · 1 FY23
Clinical Operations Development Lead
argenx
Posted 1w ago
Remote
$212K - $292K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Clinical Operations
Immunology
Senior
H-1B · 1 FY23
Scientist Preclinical Product Development
argenx
Posted 1w ago
Gent, Belgium
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Research & Development
Immunology
MID
H-1B · 1 FY23
Director, Employee Communications & Engagement – Global Commercialization
argenx
Posted 1w ago
Boston, MA, USA
$184K - $253K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Communications
Immunology
Executive
H-1B · 1 FY23
Nurse Case Manager, Colorado
argenx
Posted 1w ago
Denver
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Immunology
MANAGER
H-1B · 1 FY23
Director Market Access UK & Ireland
argenx
Posted 1w ago
Remote
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Commercial
Immunology
Executive
H-1B · 1 FY23
DT AI Platform Lead
argenx
Posted 1w ago
Gent, Belgium
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Immunology
Senior
H-1B · 1 FY23
Nurse Case Manager, Oregon
argenx
Posted 1w ago
Portland, OR
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Immunology
MANAGER
H-1B · 1 FY23
Medical Science Liaison - Houston and Austin
argenx
Posted 2w ago
Houston
$184K - $253K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Medical Affairs
Immunology
MID
H-1B · 1 FY23
Executive Assistant
argenx
Posted 2w ago
Boston, MA, USA
$76K - $105K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Immunology
Executive
H-1B · 1 FY23
Head of Specialized Sourcing
argenx
Posted 2w ago
Gent, Belgium
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Immunology
Executive
H-1B · 1 FY23
Legal Counsel, Clinical Development
argenx
Posted 2w ago
Remote
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Clinical Development
Immunology
MID
H-1B · 1 FY23
Deputy Responsible Pharmacist
argenx
Posted 2w ago
Remote
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Immunology
MID
H-1B · 1 FY23
Safety Scientist
argenx
Posted 3w ago
Remote
$164K - $226K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Research & Development
Immunology
MID
H-1B · 1 FY23
Associate Director, Medical Writing
argenx
Posted 3w ago
Remote
$164K - $226K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Medical Writing
Immunology
Executive
H-1B · 1 FY23
Head of Rewards & Recognition, Developed Markets
argenx
Posted 1mo ago
Gent, Belgium
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Immunology
Executive
H-1B · 1 FY23
Team Lead Finance Operations (AP & FBS)
argenx
Posted 1mo ago
Gent, Belgium
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Finance
Immunology
Senior
H-1B · 1 FY23
1
2
3
Next
Company Overview
Active Jobs
46
Pipeline Programs
87
Drug Products
2
Clinical Trials
92
View Full Company Profile
Therapeutic Areas
Neurology
Immunology
Oncology
Links
Company Website
Careers Page
Hematology
Rare Diseases